Keywords
Last Name
Institution
Children's Mercy Kansas City
More Search Options
Menu
Home
Find People
Find Everything
About This Site
Annual Report
Export RDF
Risks in a Trial of an Innovative Treatment of Duchenne Muscular Dystrophy.
Bos W, Westra AE, Pinxten W, Mayer MP, Lantos JD. Risks in a Trial of an Innovative Treatment of Duchenne Muscular Dystrophy. Pediatrics. 2015 Dec; 136(6):1173-7.
View in:
PubMed
subject areas
Adolescent
Child
Child, Preschool
Clinical Trials as Topic
Drug-Related Side Effects and Adverse Reactions
Ethics Committees
Ethics, Research
Humans
Muscular Dystrophy, Duchenne
Patient Safety
Risk
Treatment Outcome
Risks in a Trial of an Innovative Treatment of Duchenne Muscular Dystrophy.